Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 3;3(4):491-497.
doi: 10.21873/cdp.10245. eCollection 2023 Jul-Aug.

A Prospective Study of Intensity-modulated Radiation Therapy Using a Standard Radiation Dose for High-grade Glioma

Shigeo Takahashi  1 , Keisuke Miyake  2 , Daisuke Ogawa  2 , Masahide Anada  1 , Toshifumi Kinoshita  1 , Takamasa Nishide  1 , Toru Shibata  1
Affiliations

A Prospective Study of Intensity-modulated Radiation Therapy Using a Standard Radiation Dose for High-grade Glioma

Shigeo Takahashi et al. Cancer Diagn Progn. .

Abstract

Background/aim: We evaluated the treatment outcomes of intensity-modulated radiation therapy (IMRT) using a standard radiation dose in patients with high-grade glioma (HGG).

Patients and methods: We conducted a prospective, single-institutional, single-arm trial. Patients aged 20-75 years with histologically proven HGG were enrolled. Surgical procedures and chemotherapy regimens were not regulated. The prescribed dose of postoperative IMRT was 60 Gy in 30 fractions over six weeks. The primary endpoint was overall survival (OS). Secondary endpoints were progression-free survival (PFS), completion rate of IMRT, and Grade 3 or higher non-hematological toxicity.

Results: Between 2016 and 2019, 20 patients were enrolled. According to the World Health Organization 2016 Classification, glioblastoma, anaplastic astrocytoma, and anaplastic oligodendroglioma were present in nine, six, and five of the recruited patients, respectively. Gross total resection, partial resection, and biopsy were performed in four, nine, and seven patients, respectively. All patients received concurrent and adjuvant chemotherapy using temozolomide with or without bevacizumab. The completion rate of IMRT was 100%. The median follow-up period was 29 months (range=6-68 months). Median OS and PFS were 30 and 14 months, respectively. No patients experienced Grade 3 or higher non-hematological toxicity. The 2-year OS rates were 100%, 57%, and 33% in Radiation Therapy Oncology Group-Recursive Partitioning Analysis (RTOG-RPA) classes I/II, IV, and V, respectively (p=0.002; log-rank test).

Conclusion: IMRT using the standard radiation dose in patients with HGG can be carried out safely. RTOG-RPA class appears to be useful to estimate patient prognoses.

Keywords: IMRT; SIB; VMAT; anaplastic; glioblastoma.

PubMed Disclaimer

Conflict of interest statement

The Authors have no conflicts of interest regarding this study.

Figures

Figure 1
Figure 1. Overall survival (OS) and progression-free survival (PFS). Black solid and broken lines indicate OS and PFS, respectively.
Figure 2
Figure 2. Overall survival according to Radiation Therapy Oncology Group-Recursive Partitioning Analysis (RTOG-RPA). Black solid, gray solid, and black broken lines indicate RTOG-RPA class I/II, IV, and V, respectively.
See this image and copyright information in PMC

References

    1. Zhang Y, Wang J. Research progress on radiotherapy technology and dose fraction scheme for advanced gliomas. Transl Cancer Res. 2020;9(12):7642–7651. doi: 10.21037/tcr-20-1891. - DOI - PMC - PubMed
    1. Frosina G. Radiotherapy of high-grade gliomas: First half of 2021 update with special reference to radiosensitization studies. Int J Mol Sci. 2021;22(16):8942. doi: 10.3390/ijms22168942. - DOI - PMC - PubMed
    1. Central Nervous System Cancers Version 1.2023. NCCN Clinical Practice Guidelines in Oncology. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf. [Last accessed on April 8, 2023] - PubMed
    1. Ziu M, Kim BYS, Jiang W, Ryken T, Olson JJ. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update. J Neurooncol. 2020;150(2):215–267. doi: 10.1007/s11060-020-03612-7. - DOI - PubMed
    1. Thibouw D, Truc G, Bertaut A, Chevalier C, Aubignac L, Mirjolet C. Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy. J Neurooncol. 2018;137(2):429–438. doi: 10.1007/s11060-017-2735-y. - DOI - PubMed

LinkOut - more resources